Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken +7 more
wiley +1 more source
Reporter genes and transgenic <i>Trypanosoma cruzi</i> (Kinetoplastida, Trypanosomatidae): applications for screening new drugs against Chagas disease. [PDF]
de Sousa Oliveira DS +6 more
europepmc +1 more source
Genetically Encoded Reporter Genes for MicroRNA Imaging in Living Cells and Animals. [PDF]
Song Y, Xu Z, Wang F.
europepmc +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Recombinant Influenza A Viruses Expressing Reporter Genes from the Viral NS Segment. [PDF]
Martinez-Sobrido L, Nogales A.
europepmc +1 more source
Pathway-specific reporter genes to study stem cell biology. [PDF]
Peterson KM +5 more
europepmc +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Development and validation of Mayaro virus with luciferase reporter genes as a tool for antiviral assays. [PDF]
Marinho MDS +8 more
europepmc +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Directed Evolution of Acoustic Reporter Genes Using High-Throughput Acoustic Screening. [PDF]
Hurt RC +10 more
europepmc +1 more source

